Literature DB >> 7673138

Polo-like kinase is a cell cycle-regulated kinase activated during mitosis.

R Hamanaka1, M R Smith, P M O'Connor, S Maloid, K Mihalic, J L Spivak, D L Longo, D K Ferris.   

Abstract

Previously, we demonstrated that expression of polo-like kinase (PLK) is required for cellular DNA synthesis and that overexpression of PLK is sufficient to induce DNA synthesis. We now report that the endogenous levels of PLK, its phosphorylation status, and protein kinase activity are tightly regulated during cell cycle progression. PLK protein is low in G1, accumulates during S and G2M, and is rapidly reduced after mitosis. During mitosis, PLK is phosphorylated on serine, and its serine threonine kinase function is activated at a time close to that of p34cdc2. The phosphorylated form of PLK migrates with reduced mobility on SDS-polyacrylamide gel electrophoresis, and dephosphorylation by purified protein phosphatase 2A converts it to the more rapidly migrating form and reduces the total amount of PLK kinase activity. Purified p34cdc2-cyclin B complex can phosphorylate PLK protein in vitro but causes little increase in PLK kinase activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673138     DOI: 10.1074/jbc.270.36.21086

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  The role of Plo1 kinase in mitotic commitment and septation in Schizosaccharomyces pombe.

Authors:  K Tanaka; J Petersen; F MacIver; D P Mulvihill; D M Glover; I M Hagan
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis.

Authors:  Mark C Surka; Christopher W Tsang; William S Trimble
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

3.  Polo-like kinase is required for the fragmentation of pericentriolar Golgi stacks during mitosis.

Authors:  C Sütterlin; C Y Lin; Y Feng; D K Ferris; R L Erikson; V Malhotra
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

4.  PTEN regulates PLK1 and controls chromosomal stability during cell division.

Authors:  Zhong Zhang; Sheng-Qi Hou; Jinxue He; Tingting Gu; Yuxin Yin; Wen H Shen
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

5.  Hyperosmotic stress-induced ATF-2 activation through Polo-like kinase 3 in human corneal epithelial cells.

Authors:  Ling Wang; Reid Payton; Wei Dai; Luo Lu
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

6.  Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1.

Authors:  Barbara C M van de Weerdt; Marcel A T M van Vugt; Catherine Lindon; Jos J W Kauw; Marieke J Rozendaal; Rob Klompmaker; Rob M F Wolthuis; René H Medema
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1.

Authors:  D G Crenshaw; J Yang; A R Means; S Kornbluth
Journal:  EMBO J       Date:  1998-08-10       Impact factor: 11.598

8.  Involvement of polo-like kinase 1 (Plk1) in mitotic arrest by inhibition of mitogen-activated protein kinase-extracellular signal-regulated kinase-ribosomal S6 kinase 1 (MEK-ERK-RSK1) cascade.

Authors:  Ran Li; Dian-Fu Chen; Rong Zhou; Sheng-Nan Jia; Jin-Shu Yang; James S Clegg; Wei-Jun Yang
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

9.  Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy.

Authors:  Leo Studach; Wen-Horng Wang; Gregory Weber; Jiabin Tang; Ronald L Hullinger; Raphael Malbrue; Xiaoqi Liu; Ourania Andrisani
Journal:  J Biol Chem       Date:  2010-07-12       Impact factor: 5.157

10.  Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein.

Authors:  A Gallina; L Simoncini; S Garbelli; E Percivalle; G Pedrali-Noy; K S Lee; R L Erikson; B Plachter; G Gerna; G Milanesi
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.